AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaxa M 50mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (850mg)

Overview Sitaxa M 50mg/850mg Tablet

Diabex Duo 50mg/850mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Diabex Duo may be used independently or in conjunction with other diabetes treatments. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Consuming it with meals minimizes stomach upset. Consistent daily intake at the same time maximizes effectiveness; discontinuation should only occur under your physician's guidance. Maintaining your prescribed diet and exercise plan is crucial. Lifestyle choices are key to diabetes control. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential risk, especially with concurrent insulin or sulfonylurea use; learn to identify and manage this. This medication isn't suitable for all individuals. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption before starting treatment. Pregnant or breastfeeding individuals require medical consultation. Other medications might interact with Diabex Duo; disclose all your current medications for safety. Alcohol consumption should be limited due to its blood sugar-lowering effect. Your doctor will monitor kidney function and blood sugar levels throughout your treatment.

Uses of Sitaxa M 50mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Sitaxa M 50mg/850mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Sitaxa M 50mg/850mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitaxa M 50mg/850mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaxa M 50mg/850mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Sitaxa M 50mg/850mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitaxa M 50mg/850mg Tablet works:

Sitaxa M 50mg/850mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitaxa M 50mg/850mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaxa M 50mg/850mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitaxa M 50mg/850mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaxa M 50mg/850mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitaxa M 50mg/850mg Tablets. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Use of Sitaxa M 50mg/850mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitaxa M 50mg/850mg Tablet :

Should you forget to take your Sitaxa M 50mg/850mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaxa M 50mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Sitaxa M 50mg/850mg Tablet

Sitaxa M 50mg/850mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitaxa M 50mg/850mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Sitaxa M 50mg/850mg Tablet may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitaxa M 50mg/850mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitaxa M 50mg/850mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitaxa M 50mg/850mg) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitaxa M and seek immediate medical attention.
Sitaxa M 50mg/850mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not for use in individuals under 18 years of age.
Sitaxa M 50mg/850mg tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are possible. Prolonged use may also result in vitamin B12 deficiency.
Sitaxa M 50mg/850mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaxa M 50mg/850mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaxa M 50mg/850mg) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaxa M 50mg/850mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues (including numbness, tingling in extremities, weakness, and ataxia), urinary problems, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaxa M 50mg/850mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitaxa M 50mg/850mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitaxa M 50mg/850mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitaxa M 50mg/850mg tablets is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitaxa M 50mg/850mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaxa M 50mg/850mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitaxa M 50mg/850mg Table...
139